Advertisement
Singapore markets close in 23 minutes
  • Straits Times Index

    3,285.73
    -7.40 (-0.22%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE 100

    8,095.37
    +54.99 (+0.68%)
     
  • Bitcoin USD

    63,903.44
    -2,818.57 (-4.22%)
     
  • CMC Crypto 200

    1,365.91
    -16.66 (-1.21%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,337.80
    -0.60 (-0.03%)
     
  • Crude Oil

    83.22
    +0.41 (+0.50%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.57
    -0.91 (-0.06%)
     
  • Jakarta Composite Index

    7,159.19
    -15.34 (-0.21%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF) treatment. The company's drugs have been life-changing for children and adults living with the disease. It's also helped the company build up more than $11 billion in cash to support development of new CF drugs and candidates in other areas.